Track record
Eschenbach Andrew C. Von
An officer, director or large holder of 2 blank-check companies. Every role below was declared by Eschenbach Andrew C. Von in an SEC ownership filing.
Vehicles
2
Still live
0
Closed a deal
2 of 2
Capital involved
$140M
Every vehicle, newest first
- TriSalus Life Sciences, Inc.TLSI · Director · IPO Dec 21, 2020$12.1MCompleted
- Celularity IncCELU · Director · IPO May 21, 2019$128MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1536529. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.